Pieris Pharmaceuticals, Inc.

  • Home
  • About
  • Platform
  • Pipeline
  • Patients
  • Investors
    • Overview
    • News & Events
    • Publications
    • Presentations
    • Financial Results
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
    • Job Openings
  • Contact
Aug 29, 2019 8:00am EDT

Pieris Pharmaceuticals to Participate in Upcoming Investor Conferences

Aug 01, 2019 7:00am EDT

Pieris Pharmaceuticals Reports Second Quarter 2019 Cash Position and Provides Corporate Update

Aug 01, 2019 6:55am EDT

Pieris Pharmaceuticals Appoints Dr. Maya Said to its Board of Directors

Jul 25, 2019 8:00am EDT

Pieris Pharmaceuticals To Host Second Quarter 2019 Investor Call And Corporate Update On August 1, 2019

May 30, 2019 8:00am EDT

Pieris Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference

May 22, 2019 2:30pm EDT

Pieris Pharmaceuticals and AstraZeneca Present Single- Ascending Dose Phase 1a Data for Inhaled IL-4Rα Antagonist AZD1402/PRS-060 at the American Thoracic Society (ATS) 2019 International Conference

May 14, 2019 8:00am EDT

Pieris Pharmaceuticals to Present at the 2019 RBC Capital Markets Global Healthcare Conference

May 10, 2019 7:00am EDT

Pieris Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update

May 03, 2019 8:00am EDT

Pieris Pharmaceuticals to Host First Quarter 2019 Investor Call and Corporate Update on May 10, 2019

Apr 03, 2019 8:50am EDT

Pieris Pharmaceuticals to Present at the 2019 H.C. Wainwright Global Life Sciences Conference

  • Previous
  • 1…
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …25
  • Next
RSS
© 2023 Pieris Pharmaceuticals, Inc. All Rights Reserved.
Imprint Privacy Policy Disclaimer Sitemap Contact Us Manage Cookie Preferences